Hadassah Medical Center
Hadassah Medical Center
Israel, Jerusalem
Auala Hubert
36 years of experience
accreditations :
Clinic is certified :
Macular dystrophy treatment in Israel typically ranges from $2,200 to $4,500. Costs depend on the diagnostic complexity, medication type, and the necessity of surgical intervention. In the US, similar ocular treatments cost around $7,800 on average. Patients save approximately 56% by choosing Israeli medical centers. Treatment often includes specialist consultations and high-resolution retinal imaging.
Bookimed Expert Insight: Choosing a university hospital provides access to Nobel Prize-nominated research and elite hardware. Hadassah Medical Center treats over 1,000,000 patients annually and leads in retinal research. For complex diagnostics, Professor Anat Loewenstein at Sourasky Medical Center is a globally recognized specialist. Her expertise in laser surgery helps restore vision for thousands of patients every year. Focusing on these high-volume centers ensures access to the latest clinical trials and protocols.
| Israel | Turkey | Austria | |
| Macular dystrophy treatment | ≈ $2,200 | from $4,000 | ≈ $1,800 |
No hidden fees – just official clinic prices. Pay at the clinic for Macular dystrophy treatment upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Macular dystrophy treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Macular dystrophy treatment journey.
Day 1 - Arrival
Day 2 - Pre-Operation
Day 3 - Macular Dystrophy Treatment
Day 4 - Post-Operation
Week 1 to Week 4 - Rehabilitation
Please note that this is a general guide and individual cases may vary. Language assistance is available but transfer services are not included.
As the leading global medical tourism platform, Bookimed.com takes a huge responsibility for providing reliable information to our clients, including patients and medical centers, regarding Macular dystrophy treatment in Israel. All the information provided on Bookimed.com is grounded in research, foresight, and expertise and meets high interest related to the product and follows:
We form our listings of clinics and doctors with strict regulations of our smart automatic ranking system based on real Bookimed patient rates to provide the most objective and transparent information about clinics and medical services related to Macular dystrophy treatment in Israel.
Our experienced data scientist collects data daily, monitors, and optimizes the ranking system using machine learning and artificial intelligence to ensure that the ranking system is up-to-date and provides accurate results.
We collect the opinions of Bookimed clients only after getting medical experience with the clinic related to Macular dystrophy treatment in Israel so that everyone on the platform can trust the facility they choose. We publish positive and negative reviews, aiming at being a source for informed decision-making for our future clients.
On Bookimed.com, you may find choice and convenience to find the best medical solutions from top medical services providers related to Macular dystrophy treatment in Israel, just in one place, and often at competitive prices. The clinic’s representatives update doctors’ CVs, clinics’ capacities, before-after pictures, prices, packages, and specials by themselves shortly to deliver the freshest information. You may meet the clinic’s representative and check the date of updated content at every clinic’s page to make sure of its trustworthiness.
Our blog and supportive pieces regarding Macular dystrophy treatment in Israel are created by professional authors with at least 3-year experience in medical writing and edited by medical specialists with relevant clinical and research expertise — all carefully recruited to the team. We strive to enhance patient access to health information, making it expert but easy to understand. All pieces follow the Bookimed’s Editorial Guidelines.
We are made of people and for people — and that"s our core value. That"s why all the data presented on the platform is collected, edited, reviewed, and updated regularly by our patients, our partner clinics, and our team, including the Bookimed Medical Advisory Board, which consists of world-renowned doctors with value expertise over 20 years of practice and a positive reputation. Learn more about us and our mission.
In case you find any mistake or have any questions on the information presented on Bookimed.com related to Macular dystrophy treatment in Israel, please feel free to contact us at marketing@bookimed.com.
Professor Anat Loewenstein specializes in ophthalmology, bringing expert care to patients at Sourasky Medical Center (Ichilov).
Dr. Auala Hubert leads the Gastrointestinal Cancer Center at Hadassah Medical Center. He is a senior oncologist and radiotherapist specializing in digestive system malignancies. He graduated from Hadassah University Hospital in Jerusalem. Dr. Hubert has over 30 years of clinical experience in radiotherapy and oncology.
Israel treats wet macular degeneration using advanced anti-VEGF injections, which halt abnormal blood vessel growth. First-line therapies include Avastin, Eylea, and Lucentis, administered by retina specialists at world-class centers like Hadassah Medical Center. Regular monitoring via Optical Coherence Tomography ensures precise treatment adjustments to stabilize vision.
Bookimed Expert Insight: Israeli retina specialists like Professor Anat Loewenstein at Sourasky Medical Center emphasize `drug switching` for resistant cases. If a patient shows no improvement after three sessions of Avastin, clinics often immediately transition to Vabysmo or Eylea. This flexibility in medication choice combined with academic-level research protocols is why Israel maintains a global rank of 6 for medical service quality.
Patient Consensus: Many patients emphasize that stabilization is the realistic goal, not a full cure. They stress the importance of sticking to the injection schedule to keep their vision from worsening.
Israel offers advanced treatments for dry macular degeneration at globally recognized centers like Hadassah Medical Center. Primary strategies include AREDS2 nutritional protocols, Valeda photobiomodulation (light therapy), and pioneering OpRegen stem cell trials. These therapies aim to preserve retinal function and slow the progression of geographic atrophy.
Bookimed Expert Insight: Israeli hospitals like Hadassah and Sourasky (Ichilov) are unique because they often serve as the primary global testing sites for breakthrough therapies. For example, OpRegen stem cell therapy was actually developed within the Hadassah Medical Organization. Patients visiting Israel often gain access to these experimental protocols years before they receive standard regulatory approval in other countries.
Patient Consensus: Focus remains on slowing progression, as no universal cure exists yet. Patients emphasize the importance of monitoring for wavy lines to catch any transition to wet macular degeneration early.
Standard macular dystrophy protocols in Israel utilize anti-vascular endothelial growth factor (anti-VEGF) injections to manage wet complications. Patients typically begin with a loading phase of 3 injections over 2 months. Subsequent maintenance shifts to an Optical Coherence Tomography (OCT) guided treat-and-extend schedule.
Bookimed Expert Insight: Israeli centers like Hadassah Medical Center utilize advanced digital imaging to personalize treatment. Data shows that switching to Eylea HD or Vabysmo often increases injection intervals. This reduces hospital visits while maintaining visual acuity through precise, AI-assisted monitoring protocols.
Patient Consensus: Patients emphasize distinguishing between genetic dry dystrophy and wet complications. Many report that while the initial phase is frequent, the procedure itself is quick and painless.
Non-invasive alternatives for macular dystrophy include Photobiomodulation (Lumithera Valeda), dietary supplementation (AREDS 2 formula), and emerging gene therapies. While anti-VEGF injections treat fluid leakage in wet forms, light therapy and nutritional support focus on slowing progression in dry dystrophy without requiring needles.
Bookimed Expert Insight: Israeli medical centers like Hadassah demonstrate a high integration of research and practice. While injections remain the clinical standard for wet dystrophy, leading Israeli specialists like Professor Anat Loewenstein guide patients toward clinical trials for gene therapy. This allows eligible international patients access to next-generation treatments that are currently unavailable in many other regions.
Patient Consensus: Patients emphasize using daily UV protection and low-vision aids like magnifying apps to manage daily tasks. Many find light therapy a gentle alternative but highlight that vitamins are a lifelong commitment rather than a quick fix.
Israel is a global hub for experimental macular treatments. Key advances include OpRegen stem cell therapy for dryness and innovative retinal implants. Israeli clinics participate in international clinical trials for gene therapies like OPGX-BEST1 and offer high-resolution monitoring through locally developed diagnostic tools.
Bookimed Expert Insight: While many search for a definitive cure, Israel's real strength is trial access. Hadassah Medical Center attracts patients globally because it uniquely combines Nobel Prize-winning research with daily clinical practice. If standard injections fail, their participation in global trials for Best disease and dry AMD offers options unavailable elsewhere.
Patient Consensus: Current care focuses on managing quality of life through low-vision aids and digital accessibility software. Patients emphasize monitoring clinical trial databases regularly for recruitment updates rather than expecting an immediate local cure for genetic conditions.
Top-rated macular specialists in Israel are located at premier institutions like Tel Aviv Sourasky Medical Center and Hadassah Medical Center. Renowned experts including Professor Anat Loewenstein and Dr. Adiel Barak specialize in advanced retinal pathology, surgical repairs, and innovative dystrophy management in Jerusalem and Tel Aviv.
Bookimed Expert Insight: While big centers like Hadassah serve 1,000,000 patients annually, private facilities like Assuta offer faster scheduling. Data shows Israel ranks 6th globally for medical requests, reflecting high confidence in specialized ophthalmic care. Choosing a Jerusalem-based hospital provides access to Nobel Prize-winning medical expertise.
Patient Consensus: Many patients suggest checking private availability if public wait times exceed two months. Confirming if your specialist performs regular anti-VEGF injections is a common practical tip for managing macular conditions.
No, you do not need to be a resident to receive medical treatment in Israel. The country maintains a specialized medical tourism infrastructure for international patients. Non-residents access high-quality care through private clinics or international departments of major medical centers like Hadassah.
Bookimed Expert Insight: Israeli medical centers often pair academic research with clinical practice. Hadassah Medical Center was nominated for a Nobel Peace Prize. This environment often gives international patients earlier access to experimental therapies and advanced diagnostic imaging. You should contact clinics in Jerusalem or Tel Aviv to confirm their current intake criteria.
Patient Consensus: Patients report that while macular dystrophy has no cure, the specialized care in Israel helps manage complications effectively. Many appreciate the availability of advanced Anti-VEGF injections and supportive low-vision technology.
Israel is a premier neurosurgery hub due to its fusion of high-density medical innovation and elite surgical expertise. Top facilities like Sheba Medical Center integrate AI-guided navigation and real-time intraoperative MRI. Specialized centers report 98% success rates for complex procedures including awake craniotomy and movement disorder treatments.
Bookimed Expert Insight: Data shows a clear divide between public and private options in Israel. Private centers like Assuta Medical Center perform over 92,000 operations annually and allow patients to select their specific lead surgeon. This is a vital advantage for complex cases where a specific expert like Dr. Eli Ashkenazi is preferred for his 1,000+ spine surgery record.
Patient Consensus: Patients emphasize bringing original imaging on a USB for local review to streamline the surgical plan. They also note that private packages often include hotel coordination and airport transfers, making the logistics much smoother.
Israeli neurosurgeons treat a full spectrum of conditions ranging from brain and spinal tumors to complex functional disorders. Specialized centers utilize advanced technologies like Gamma Knife, deep brain stimulation, and intraoperative MRI to manage epilepsy, Parkinson disease, and cerebrovascular pathologies with high precision.
Bookimed Expert Insight: Israeli hospitals often combine specialties to handle complex cases. At Sourasky Medical Center, neurosurgeons like Dr. Zvi Lidar bridge neurosurgery and orthopedics for spinal care. This multidisciplinary approach allows clinics to perform 34,000+ operations annually. Choosing a facility with this crossover expertise often leads to more comprehensive treatment plans for degenerative diseases.
Patient Consensus: Patients value the ability to access specialized treatments like fluorescence-guided surgery for tumors which are often unavailable elsewhere. Many note that the staff is fluent in English and provides clear communication through teleconsultations before traveling.
Israel is home to world-renowned neurosurgery centers like Sourasky Medical Center, Sheba Medical Center, and Hadassah Medical Center. These facilities are globally ranked for treating complex brain tumors, spinal disorders, and movement diseases. They utilize advanced technologies like Gamma Knife, robotic systems, and intra-operative MRI.
Bookimed Expert Insight: Our data shows that while most patients focus on Tel Aviv, Rambam Medical Center in Haifa offers unique expertise in neuro-trauma. It operates a specialized neuro-ICU and serves nearly 1 million patients annually. This makes it an essential choice for complex post-trauma brain surgeries that requires intensive recovery support.
Patient Consensus: Patients note it is important to start consultations early. They often highlight that the precision and follow-up care for complex brain tumors exceeded their expectations. One patient emphasized how quickly they could connect with top professors for second opinions during critical neurosurgical cases.
Israel's leading neurosurgeons include Prof. Zvi Ram, Prof. Shlomi Constantini, and Prof. Itzhak Fried at Sourasky Medical Center. These specialists hold leadership roles in the European Association of Neurosurgical Societies (EANS) and the World Society for Stereotactic and Functional Neurosurgery (WSSFN). They utilize advanced intraoperative mapping and robotic systems.
Bookimed Expert Insight: Data from Sourasky and Sheba indicates a strong correlation between high surgical volumes and patient safety. For example, Sourasky performs 34,000+ operations annually with a 90% oncology success rate. Patients seeking complex tumor removals should prioritize centers like these where surgeons perform hundreds of specific cases each year.
Patient Consensus: Patients emphasize the importance of finding a surgeon who specializes specifically in your condition rather than a generalist. Many note that high-volume centers provide better access to English-speaking staff and coordinated care for international visitors.
International neurosurgery patients in Israel must provide comprehensive medical records including recent MRI or CT scans translated into English. Admission requires a clinical review by specialists to confirm treatment feasibility. Hospitals often mandate full advance payment or a significant deposit before confirming surgery dates or issuing visa support letters.
Bookimed Expert Insight: Data shows that top Israeli facilities like Sheba Medical Center and Hadassah Medical Center handle massive patient volumes, exceeding 1,000,000 people annually. This high demand means clinics prioritize complex or rare cases over routine procedures. Patients with unique or high-risk conditions often receive faster admission approval than those seeking standard treatments available elsewhere.
Patient Consensus: Patients note that having all imaging results ready in English is essential for quick scheduling. Many emphasize that while the medical care is excellent, coordinating around Shabbat closures is necessary to avoid unexpected diagnostic delays.
A standard stay for neurosurgery in Israel ranges from 10 to 14 days for uncomplicated cases. Patients undergoing complex procedures like brain tumor removal or deep brain stimulation often require 4 to 6 weeks. This timeline covers pre-operative diagnostics, the surgical procedure, and essential post-operative monitoring.
Bookimed Expert Insight: Data from Sourasky Medical Center shows they treat over 400,000 patients annually with high success rates. Clinics with such high volumes, like Hadassah or Assuta, often have streamlined discharge protocols. This helps international patients transition to hotel-based recovery faster while maintaining access to top specialists.
Patient Consensus: Patients note it is vital not to rush home too early. Some travelers extended their stay to 3 weeks due to swelling or to ensure they received final surgeon clearance before flying.
Israeli neurosurgery uses robotic guidance, real-time 3D imaging, and incisionless technologies to minimize physical trauma. Systems like Mazor Robotics provide sub-millimeter precision for spine implants. MRI-guided focused ultrasound (MRgFUS) treats tremors without incisions. These advanced tools ensure high accuracy and reduce recovery times.
Bookimed Expert Insight: Israeli clinics like Sourasky or Hadassah integrate proprietary Israeli-born technologies like Surgical Theater before they hit global markets. Our data shows these centers often use VR flight-through models for pre-surgical planning. This allows surgeons to rehearse complex cases, which is a key factor in their 90% success rates.
Patient Consensus: Patients note that technologies like the Gamma Knife allowed them to return home in days rather than weeks. Many move from traditional 10cm incisions to cuts under 2cm when using robotic-assisted systems.
Israel is a global leader in neurosurgery due to its integration of proprietary medical innovations and internationally trained specialists. High-capacity centers like Sourasky Medical Center (Ichilov) perform over 34,000 annual surgeries. Patients access advanced techniques like awake craniotomy and MR-guided focused ultrasound.
Bookimed Expert Insight: Israeli neurosurgery stands out because of the high concentration of dually certified experts. Many top surgeons, such as Dr. Zvi Lidar, are certified to practice in both Israel and the USA. This ensures that patients receive American-standard surgical care while staying in Tel Aviv or Jerusalem. Our data shows that private centers like Assuta offer significantly faster access to these specific specialists compared to the public system.
Patient Consensus: Patients note it is important to confirm a surgeon's specific volume of cases for your exact condition. They also value the ability to get expert second opinions quickly through online consultations with world-renowned professors.
Sheba Medical Center and Sourasky Medical Center (Ichilov) are among the best neurosurgery hospitals in Israel. These JCI-accredited facilities perform thousands of operations annually. They utilize advanced technologies like CyberKnife and intraoperative MRI to treat complex brain tumors and cerebrovascular lesions.
Bookimed Expert Insight: Our data shows that top Israeli centers like Sourasky and Hadassah perform over 40,000 total operations yearly. This high volume allows surgeons to maintain a 90% success rate even in complex oncology cases. Patients seeking robotic spine surgery or deep brain stimulation should focus on these high-capacity municipal centers for the most experienced teams.
Patient Consensus: Patients appreciate that some hospitals quickly coordinate consultations even during regional strikes. Families of pediatric patients especially value surgeons trained at prestigious international institutions.
Israel's leading neurosurgeons include Professor Zvi Ram, Professor Shlomi Constantini, and Professor Itzhak Fried at Sourasky Medical Center. These experts specialize in awake craniotomy, pediatric brain tumors, and functional mapping. Most hold JCI accreditation and international fellowships from institutions like Johns Hopkins and Yale.
Bookimed Expert Insight: Data shows that top-tier Israeli neurosurgeons, such as those at Sourasky Medical Center, often hold dual board certifications in Israel and the US. This unique crossover ensures patients receive American-standard protocols. These specialists typically manage over 34,000 annual operations, providing high-volume clinical experience that smaller private clinics cannot match.
Patient Consensus: Patients note that highly qualified doctors like Professor Shlomo Constantini provide satisfactory answers quickly. People emphasize that outcomes often depend on the hospital’s integrated resources rather than just a doctor's prestige.
Israel is a global leader in neurosurgery, treating complex brain and spinal conditions using robotic-assisted and minimally invasive techniques. Highly specialized units at JCI-accredited centers like Sourasky Medical Center (Ichilov) and Hadassah Medical Center focus on neuro-oncology, pediatric neurosurgery, and functional procedures.
Bookimed Expert Insight: Israeli neurosurgical departments often function as rapid-response hubs for international patients. Data shows that large centers like Sourasky, which serves 1,800,000 patients annually, can organize expert video consultations in a very short time. This speed is critical for neuro-oncology cases where starting treatment a few days earlier significantly impacts outcomes.
Patient Consensus: Patients note that Israeli teams often accept high-risk cases that other hospitals decline. They emphasize the importance of using local coordinators to manage travel logistics or potential local disruptions during their two-week stay.
International patients traveling to Israel for neurosurgery require a valid passport, an entry permit or medical visa, and a formal hospital invitation. You must provide recent MRI or CT scans in DICOM format and detailed medical summaries. Proof of private health insurance and financial stability are also mandatory for border entry.
Bookimed Expert Insight: Our data shows that top neurosurgeons at Hadassah Medical Center and Sourasky often request records 4–6 weeks before arrival. Submitting these early prevents appointment shifts. High-volume centers with over 30,000 annual operations have dedicated portals for secure DICOM file uploads. Using these ensures your surgeon reviews high-quality images before you land in Tel Aviv.
Patient Consensus: Patients emphasize bringing physical copies and digital backups of all scans on a USB drive. They also note that private insurance needs pre-authorization specifically for neurosurgery to avoid payment delays at the clinic.